<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2023.8611</article-id>
<article-id pub-id-type="publisher-id">OR-50-4-08611</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Retracted] MicroRNA‑15b promotes proliferation and invasion of non‑small cell lung carcinoma cells by directly targeting TIMP2</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Haowen</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhan</surname><given-names>Yu</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Jin</surname><given-names>Jingjing</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Chunhong</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Wenfeng</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection">
<month>10</month>
<year>2023</year></pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>08</month>
<year>2023</year></pub-date>
<volume>50</volume>
<issue>4</issue>
<elocation-id>174</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Wang et al.</copyright-statement>
<copyright-year>2023</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Rep 37: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="37" page="3305" id="RA1" xlink:href="10.3892/or.2017.5604" ext-link-type="doi">3305&#x2013;3312</related-article>, 2017; DOI: 10.3892/or.2017.5604</p>
<p>Following the publication of this paper, it was drawn to the Editor&#x0027;s attention by a concerned reader that certain of the cell migration and invasion images shown in Figs. 3B and D and 6C were strikingly similar to data that had already appeared in an article written by different authors at different research institutes [Liu C, Guan H, Wang Y, Chen M, Xu B, Zhang L, Lu K, Tao T and Zhang X: miR-195 inhibits EMT by targeting FGF2 in prostate cancer cells. PLoS One 9: e0144073, 2015].</p>
<p>Owing to the fact that the contentious data in the above article had already been published prior to its submission to <italic>Oncology Reports</italic>, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
